BSC® Solutions
VOICES
Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.
BSC® Solutions
VOICES
Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.

Therapy Areas
Ophthalmology
Strategic statistical consulting for vision-critical devices
Overview
BSC provides statistical expertise for ophthalmic devices and therapeutics, including intraocular lenses (IOLs), refractive surgery systems, glaucoma treatments, and retinal disease management technologies. Our experience spans both surgical and diagnostic ophthalmology devices.
Specialized Capabilities
Visual acuity endpoint design (ETDRS, logMAR). Handling of inter-eye correlation in bilateral studies. Non-inferiority margin justification for ophthalmic devices. Intraocular pressure modeling for glaucoma devices. Retinal imaging endpoint assessment.
Regulatory Experience
We understand ophthalmology division expectations for vision endpoint assessment, including appropriate vision testing protocols, handling of fellow-eye effects, and long-term safety monitoring for implantable devices. Our team has successfully navigated discussions around appropriate comparators and study designs.
Representative Studies
Intraocular lenses, IOLS, (monofocal, multifocal, toric)
Glaucoma drainage devices and minimally invasive procedures
Laser refractive surgery systems
Retinal treatment devices and drug delivery systems
Ophthalmic diagnostic imaging devices

Design
We use innovative approaches — Bayesian design, adaptive clinical trial design, and Propensity Score Matching — to reduce costs, overcome limited data access, and minimize bias in non-randomized studies.

Analyze

Advance
Testimonials
See what our sponsors say about BSC®
On Experience
“Battle ground tested.”
“There is nothing that David and team haven’t seen over the years – the good, bad, and ugly.”
• Vice President, Clinical Operations
• Former FDA Regulator
• CEO, Medical Device Company
Featured Resources
Get regulatory insights
from BSC®
Featured Resources
Get regulatory insights
from BSC®
Featured Resources
Get regulatory insights
from BSC®
Featured Resources
Get regulatory insights
from BSC®
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Use your preferred LLM to explore BSC®
Use your preferred LLM to explore BSC®

